Laura J. Esserman
Tracked across 1 events · 8 articles · First seen May 16, 2026 · Last active May 16, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Laura J. Esserman is leading research at the University of California, San Francisco, to better understand breast cancer risk and offer more tailored screening advice, including the WISDOM trial.
May 16, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Laura J. Esserman live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard